Abstract
Background
Increased oxycodone use has been associated with adverse drug events, non-medical use and overdose deaths.
Objectives
To explore patterns of non-opioid, weak opioid and strong opioid use prior to initiation of oxycodone for non-cancer pain in a predominantly older Australian population.
Methods
A retrospective study was conducted using the Australian Government Department of Veterans’ Affairs administrative claims database. Analgesic use 12 months prior to incident dispensing of oxycodone was determined for people in the community and in residential aged-care facilities (RACFs). Log-binomial regression was used to compute adjusted rate ratios (RRs) and 95 % confidence intervals (95 % CIs) for the use of other analgesics prior to initiating oxycodone.
Results
Of 10,791 people who initiated oxycodone in 2010, 26 % in community settings and 13 % in RACFs were not dispensed other analgesics in the 12 months prior to initiating oxycodone. Thirty-four percent and 20 % of those in community settings and RACFs, respectively, were not dispensed other analgesics in the previous 4 months. Co-morbidity had little impact on prior analgesic use. Each additional co-morbid condition was associated with a 1.4 % increased likelihood (RR 1.014, 95 % CI 1.012–1.016; p < 0.0001) and a 1.2 % increased likelihood (RR 1.012, 95 % CI 1.009–1.015; p < 0.0001) of being dispensed another analgesic prior to initiating oxycodone in community and RACF settings, respectively.
Conclusions
Oxycodone is frequently initiated for non-cancer pain without first trialing other analgesics. This highlights the need for prescribing practices to be reviewed in light of increasing concerns about adverse drugs events and death due to oxycodone, particularly in older people.
References
Leong M, Murnion B, Haber PS. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J. 2009;39:676–81.
del Pozo JG, Carvajal A, Viloria JM, et al. Trends in the consumption of opioid analgesics in Spain: higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol. 2008;64:411–5.
Hamunen K, Paakkari P, Kalso E. Trends in opioid consumption in the Nordic countries 2002–2006. Eur J Pain. 2009;13:954–62.
Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166–75.
Manchikanti L, Helm S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(Suppl 3):S9–38.
Sawyer P, Bodner EV, Ritchie CS, et al. Pain and pain medication use in community-dwelling older adults. Am J Geriatr Pharmacother. 2006;4:316–24.
Pokela N, Bell JS, Lihavainen K, et al. Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. Am J Geriatr Pharmacother. 2010;8:233–44.
Marcum ZA, Perera S, Donohue JM, et al. Analgesic use for knee and hip osteoarthritis in community-dwelling elders. Pain Med. 2011;12:1628–36.
van Ojik AL, Jansen PA, Brouwers JR, et al. Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids. Drugs Aging. 2012;29:615–25.
Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686–91.
Pergolizzi J, Böger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly. Pain Pract. 2008;8:287–313.
Braden JB, Russo J, Fan MY, et al. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med. 2010;170:1425–32.
Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Arch Intern Med. 2010;152:85–92.
Manchikanti L, Fellows B, Ailinani H, et al. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13:401–35.
Rintoul AC, Dobbin MD, Drummer OH, et al. Increasing deaths involving oxycodone, Victoria, Australia, 2000–09. Inj Prev. 2010;17:254–9.
Darke S, Duflou J, Torok M. Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999–2008. J Forensic Sci. 2011;56:690–3.
Roxburgh A, Bruno R, Larance B, et al. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195:280–4.
World Health Organization. WHO pain relief ladder. http://www.who.int/cancer/palliative/painladder/en/ (Accessed 15 March 2013).
Royal Australasian College of Physicians. Prescription opioid policy: improving management of chronic non-malignant pain and prevention of problems associated with prescription opioid use. http://www.racp.org.au (Accessed 15 March 2013).
NPS Better choices Better health. NPS prescribing practice review 51: opioids in chronic non-cancer pain: use a planned approach. http://www.nps.org.au/health_professionals/publications/prescribing_practice_review/current/prescribing_practice_review_51 (Accessed 15 March 2013).
Australian Government Department of Veterans’ Affairs. Treatment population statistics: quarterly report; 2010. http://www.dva.gov.au/aboutDVA/Statistics/Documents/TpopDec2010.pdf (Accessed 2 Aug 2013).
WHO Collaborating Centre for Drug Statistics Methodology. The Anatomical Therapeutic Chemical classification system. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. http://www.whocc.no/atcddd/ (Accessed 15 March 2013).
Australian Government Department of Health and Ageing. Pharmaceutical benefits scheme. http://www.pbs.gov.au/pbs/home (Accessed 15 March 2013).
National Centre for Classification in Health. The International Statistical Classification of Diseases and Related Health Problems. 10th revision, Australian modification (ICD-10-AM). 6th ed. Sydney: National Centre for Classification in Health, Faculty of Health Sciences, University of Sydney; 2005.
Vitry A, Wong SA, Roughead EE, et al. Validity of medication-based co-morbidity indices in the Australian elderly population. Aust N Z J Public Health. 2009;33:126–30.
Williams CM, Maher CG, Hancock MJ, et al. Low back pain and best practice care: a survey of general practice physicians. Arch Intern Med. 2010;170:271–7.
Thomas E, Mottram S, Peat G, et al. The effect of age on the onset of pain interference in a general population of older adults: prospective findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain. 2007;129:21–7.
Leveille SG, Jones RN, Kiely DK, et al. Chronic musculoskeletal pain and the occurrence of falls in an older population. JAMA. 2009;302:2214–21.
Arola HM, Nicholls E, Mallen C, et al. Self-reported pain interference and symptoms of anxiety and depression in community-dwelling older adults: can a temporal relationship be determined? Eur J Pain. 2010;14:966–71.
Karttunen N, Lihavainen K, Sipilä S, et al. Musculoskeletal pain and use of analgesics in relation to mobility limitation among community-dwelling persons aged 75 years and older. Eur J Pain. 2012;16:140–9.
Cicero TJ, Surratt H, Inciardi JA, et al. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Pharmacoepidemiol Drug Saf. 2007;16:827–40.
Wisniewski AM, Purdy CH, Blondell RD. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits. J Addict Dis. 2008;27:1–11.
Lee M, Silverman SM, Hansen H, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145–61.
Gustavsson A, Bjorkman J, Ljungcrantz C, et al. Pharmaceutical treatment patterns for patients with a diagnosis related to chronic pain initiating a slow-release strong opioid treatment in Sweden. Pain. 2012;153:2325–31.
Lapane KL, Quilliam BJ, Chow W, et al. Pharmacologic management of non-cancer pain among nursing home residents. J Pain Symptom Manage. 2013;45:33–42.
Nishtala PS, McLachlan AJ, Bell JS, et al. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract. 2011;17:97–103.
Scherder E, Herr K, Pickering G, et al. Pain in dementia. Pain. 2009;145:276–8.
Mitchell SJ, Hilmer SN, McLachlan AJ. Clinical pharmacology of analgesics in old age and frailty. Rev Clin Gerontol. 2009;19:103–18.
Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med. 2010;170:1979–86.
Rossi S, editor. Australian medicines handbook. Adelaide: Australian Medicines Handbook Ltd; 2012.
Bell JS, Kalisch LM, Ramsay EN, et al. Prescriber feedback to improve the quality use of medicines among older people: the Veterans’ MATES Program. J Pharm Pract Res. 2011;41:316–9.
Australian Institute of Health and Welfare. Health care usage and costs: a comparison of veterans and war widows and widowers with the rest of the community. http://www.aihw.gov.au/publication-detail/?id=6442467407 (Accessed 2 Aug 2013).
Acknowledgments
This work has been produced as part of the Australian Government Department of Veterans’ Affairs Veterans’ Medicines Advice and Therapeutics Education Services (Veterans’ MATES) Program. This program is provided by the Quality Use of Medicines and Pharmacy Research Centre, Sansom Institute, University of South Australia in association with the Discipline of General Practice, University of Adelaide; the Discipline of Public Health, University of Adelaide; the Repatriation General Hospital, Daw Park; NPS MedicineWise; the Australian Medicines Handbook; and the Drug and Therapeutic Information Service. Veterans’ MATES Program materials are available from http://www.veteransmates.net.au
Conflict of interest
The authors declare that they have no conflicts of interest relevant to the content of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gadzhanova, S., Bell, J.S. & Roughead, E.E. What Analgesics Do Older People Use Prior to Initiating Oxycodone for Non-Cancer Pain? A Retrospective Database Study. Drugs Aging 30, 921–926 (2013). https://doi.org/10.1007/s40266-013-0115-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-013-0115-7